BRIEF published on 02/03/2026 at 07:05, 3 months 17 days ago Sartorius Reports Strong Growth and Positive Outlook for 2026 Investment Strategy Bioprocess Solutions 2026 Outlook Financial Results 2025 Sartorius Growth
BRIEF published on 02/03/2026 at 07:05, 3 months 17 days ago Sartorius annonce une forte croissance et des perspectives positives pour 2026 Stratégie D'investissement Solutions De Bioprocédés Résultats Financiers 2025 Perspectives Pour 2026 Croissance De Sartorius
BRIEF published on 02/03/2026 at 07:05, 3 months 17 days ago Newron Pharmaceuticals Highlights Benefits of Evenamide for Schizophrenia Clinical Trials Schizophrenia Newron Pharmaceuticals Evenamide Treatment-resistant
BRIEF published on 02/03/2026 at 07:05, 3 months 17 days ago Newron Pharmaceuticals met en avant les bienfaits de l'Evenamide pour la schizophrénie Essais Cliniques Schizophrénie Newron Pharmaceuticals Evenamide Résistant Au Traitement
BRIEF published on 02/03/2026 at 07:05, 3 months 17 days ago AT&S Third Quarter Report Shows Positive Profit Growth Revenue Growth EBITDA Margin Cost Optimization Profit Increase Market Forecast
BRIEF published on 02/03/2026 at 07:05, 3 months 17 days ago Le rapport du troisième trimestre d'AT&S fait état d'une croissance positive des bénéfices Croissance Des Revenus Marge D'EBITDA Optimisation Des Coûts Prévisions Du Marché Augmentation Des Profits
BRIEF published on 02/03/2026 at 07:05, 3 months 17 days ago Sanofi Signs €1 Billion Share Buyback Mandate Share Buyback Investment Financial Strategy Biopharma Sanofi
BRIEF published on 02/03/2026 at 07:05, 3 months 17 days ago Sanofi signe un mandat de rachat d'actions de 1 milliard d'euros Investissement Rachat D'actions Stratégie Financière Biopharma Sanofi
BRIEF published on 02/03/2026 at 06:35, 3 months 17 days ago R&S Group Reports 47% Increase in FY2025 Net Sales EBITDA Margin Order Backlog R&S Group Kyte Powertech FY2025 Sales
BRIEF published on 02/03/2026 at 06:35, 3 months 17 days ago Le groupe R&S annonce une hausse de 47 % de son chiffre d'affaires net pour l'exercice 2025. Marge D'EBITDA Groupe R&S Carnet De Commandes Kyte Powertech Ventes De L'exercice 2025
Published on 05/21/2026 at 01:25, 2 hours 43 minutes ago Mongolia Growth Group Announces Completion of Arrangement and Changes to the Board and Executive Leadership
Published on 05/20/2026 at 22:40, 5 hours 28 minutes ago Jaguar Health Reports First Quarter 2026 Financials
Published on 05/20/2026 at 22:15, 5 hours 53 minutes ago Fox River Resources Corporation Obtains Interim Order for Plan of Arrangement and Provides Details of Special Meeting
Published on 05/20/2026 at 15:28, 12 hours 40 minutes ago Sarama Resources Announces Private Equity Placement of A$1.5m
Published on 05/20/2026 at 15:01, 13 hours 7 minutes ago Kidoz Inc. Appoints Tarrnie Williams Jr. as Chief Operating Officer
Published on 05/20/2026 at 22:00, 6 hours 8 minutes ago Nebius and Bloom Energy partner to power AI infrastructure build-out
Published on 05/20/2026 at 21:35, 6 hours 33 minutes ago IGEL and Zscaler Release Healthcare Security Blueprints for Distributed Care Delivery
Published on 05/20/2026 at 20:15, 7 hours 53 minutes ago EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S expands capacity for AI substrates
Published on 05/20/2026 at 19:34, 8 hours 34 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Final Results Announcement
Published on 05/20/2026 at 19:34, 8 hours 34 minutes ago EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S intends to issue a (Hybrid) Convertible Bond and/or a Hybrid Bond; no dividend for the financial year 2025/26
Published on 05/20/2026 at 18:00, 10 hours 8 minutes ago General shareholders meeting of 20 May, 2026
Published on 05/20/2026 at 18:00, 10 hours 8 minutes ago General shareholders meeting of 20 May, 2026
Published on 05/20/2026 at 17:45, 10 hours 23 minutes ago Report on share repurchases from 13 to 19 May 2026